Healthcare -
Biotechnology - NASDAQ - US
$ 1.565
7.19 %
$ 101 M
Market Cap
-1.01
P/E
INZY - TOTAL CURRENT ASSETS
Total Current Assets INZY - Inozyme Pharma, Inc.
196 M
LAST VALUE
30.44%
2 YEAR CAGR
35.31%
5 YEAR CAGR
0.00%
10 YEAR CAGR